Cellular Biomedicine Group Inc (NASDAQ:CBMG)

17.65
Delayed Data
As of May 23
 0.00 / 0.00%
Today’s Change
5.50
Today|||52-Week Range
22.75
+56.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$315.5M

Company Description

Cellular Biomedicine Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. Its technology includes immune system therapy for treatment of cancer indications and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases The company was founded in 2009 and is headquartered in Cupertino, CA.

Contact Information

Cellular Biomedicine Group, Inc.
19925 Stevens Creek Boulevard
Cupertino California 94301
P:(408) 973-7884
Investor Relations:
(650) 566-5064

Employees

Shareholders

Individual stakeholders24.30%
Other institutional12.13%
Mutual fund holders1.82%

Top Executives

Bi Zuo LiuCEO, Chief Financial Officer Director
Cheng Xiang DaiSenior Vice President-Clinical Development
Yi Hong YaoChief Scientific Officer
Li ZhangVice President-Technology & Manufacturing
Andrew ChanSecretary, Chief Legal Officer & SVP